BackIntra-Cellular Therapies Overview

Intra-Cellular Therapies Inventory

Intra-Cellular Therapies's inventory is $26M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$26.28M
↑ 125.66% YoYΔ $14.64M vs prior year quarter

Peer trimmed avg / median

Loading

Intra-Cellular Therapies Inventory History

Loading

Intra-Cellular Therapies vs. peers: Inventory Comparison

Loading

Intra-Cellular Therapies Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Intra-Cellular Therapies (ITCI) FAQ

The latest inventory for ITCI is $26M as of December 2024. That compares with $12M in the prior-year period — up 125.7% year over year. Investors often review this figure alongside Intra-Cellular Therapies's historical trend and sector peers before judging valuation or financial health.

Over the past year, ITCI's inventory moved from $12M to $26M — a 125.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Intra-Cellular Therapies's operating scale or balance-sheet position.

A inventory figure of $26M for ITCI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ITCI's inventory ($26M), review year-over-year change from $12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Intra-Cellular Therapies's inventory against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.